Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

CMV is the most common congenital infection in newborns worldwide. Congenital CMV causes sensorineural hearing loss in a significant proportion of infected newborns, while the majority of newborns are asymptomatic. In the last three years there have been significant advances in the diagnosis and treatment of congenital CMV. We have developed practical evidence based guidelines for the management of congenital CMV.

Original publication

DOI

10.1016/j.earlhumdev.2011.08.021

Type

Journal article

Journal

Early Hum Dev

Publication Date

11/2011

Volume

87

Pages

723 - 728

Keywords

Algorithms, Cytomegalovirus, Cytomegalovirus Infections, Drug Monitoring, Evidence-Based Medicine, Ganciclovir, Hearing Loss, Sensorineural, Humans, Infant, Newborn, Neonatal Screening, Saliva, Sensitivity and Specificity, Viral Load